A share price down 23 per cent this calendar year. A Q2 FY27 topline hit by a 250-350 basis point festive calendar shift. Store additions running well below the earlier triple-digit annual outlook.
The Indian footwear and specialty retail space has been one of the harder segments for retail investors to position through 2026. Discretionary consumption has been uneven, store expansion has been held back by elevated rentals, and the entire category has traded well below its 2024 highs.
The name at the centre of that question is Metro Brands (NSE: METROBRA). The stock trades at ₹903, down from the 52-week high of ₹1,250, and has corrected 23% in calendar year 2026 to date. The company operates the Metro, Mochi, Walkway and Crocs stores, with newer partnerships for FILA, Foot Locker and Clarks building out the next phase.
Emkay Research has maintained its BUY rating while cutting its target price to ₹1,150 from ₹1,250 — an 8% reduction, with the current target implying 27% upside. “We maintain BUY on Metro Brands, while cutting our TP by ~8% to Rs1,150 from Rs1,250 (50x Sep-28E EPS vs 54x earlier), on a relatively slower ramp-up of FILA/Foot Locker/Walkway. The TP cut is multiple-led as the cut in topline growth is offset by better margins on slower expansion,” the Emkay Research note states.
The Quarter Reviewed
Revenue grew approximately 12% year-on-year, in line with estimates, but was impacted by a festive calendar shift that pushed roughly 250-350 basis points of growth into Q3. Channel growth was broad-based, with offline and e-commerce both running at 11-12% year-on-year. Online mix stayed flat at 14.2% of topline. Revenue per square foot for in-store sales was broadly flat at ₹4,250 against ₹4,300 in Q2 FY26.
The Margin Beat
The operational beat was at the gross margin line. “Gross margin expanded by ~210bps yoy to 57.4%, driven by lower discounting during end-of-season sales along with a slight improvement in mark-ups,” the Emkay Research note states.
EBITDA margin expansion was more modest at approximately 80 basis points to 27%, held back by employee expenses up approximately 140 basis points due to minimum wage hikes and team investments. EBITDA at ₹1.9 billion grew approximately 16% year-on-year — 4% above Emkay’s estimate. Reported PAT came in at ₹758 million, up 12% year-on-year.
The Store Story
Net store additions were 12 in Q2 FY27 and 21 in H1 FY27 — well below the 58 net additions in H1 FY26, and well below the triple-digit annual outlook. The slowdown is attributed to elevated rentals and tightened store-opening criteria. Premium formats Crocs, Metro and Mochi saw 5, 4 and 2 additions respectively, while Walkway expansion slowed with just 2 additions. “Management expects store additions to improve in 2HFY27, while remaining focused on opening profitable stores,” the note observes.
The Pipeline
Clarks’ women’s range is now available across 400-plus MBOs, and a limited men’s range across 100-plus MBOs. “The complete store-exclusive range is expected to become available in 3Q and on its D2C website, with Clarks EBOs planned for 2HFY27, subject to supply and assortment stabilization,” the note states. Walkway’s existing-store initiatives continue to perform well, while the company refines its new-store expansion strategy.
What Emkay Thinks Metro Brands Is Worth
| Rating & Valuation | Value |
|---|---|
| Current Market Price | ₹903 |
| Target Price | ₹1,150 (cut from ₹1,250) |
| Upside | +27.4% |
| Rating | BUY (Maintained) |
| Valuation Basis | 50x Sep-28E EPS |
| Market Cap | ₹246 bn |
| 52-week Range | ₹1,250 / ₹807 |
| CY26-TD Performance | -23% |
| Cash as % of Market Cap (FY26-end) | ~40% |
The target cut is multiple-led — from 54x to 50x September 2028 estimated EPS — reflecting the slower ramp-up in FILA, Foot Locker and Walkway. The underlying earnings forecast is largely preserved.
The Balance Sheet Optionality
“Despite building in a slower ramp-up, we maintain our positive stance on the back of strong mid-teens growth prospects, bolstered by its existing portfolio (Metro/Mochi/Walkway/Crocs), new scalable partnerships (Foot Locker/FILA/Clarks), and optionality from a healthy balance sheet (~40% cash at FY26-end),” the Emkay Research note states.
“The stock has been an underperformer (CY26TD: -23%), and new growth engines/leadership investments have to fire for the stock to re-rate, in our view,” the note states. The Clarks EBO launch has to execute on its 2H FY27 timeline. The FILA and Foot Locker ramp-up has to pick up pace. And the overall store addition trajectory has to recover toward management’s earlier triple-digit guidance.
The Key Risks
The thesis sits on three operational levers. The festive shift that hit Q2 needs to actually show up as third-quarter benefit, failing which the full-year topline guidance comes into question. The new partnerships (Clarks, FILA, Foot Locker) need to scale as projected, and any further delays would weigh on the earnings trajectory. The store expansion recovery in the second half of FY27 needs to come through, failing which the forward growth narrative weakens.
A sustained slowdown in discretionary consumption, prolonged rental inflation, or any delay in the Clarks exclusive brand outlet rollout would be the specific triggers that could pressure the thesis.
